157 related articles for article (PubMed ID: 36991553)
1. As-Required Filgrastim for Late-Onset Neutropenia Complicating Long-Term Clozapine Treatment: a Case Report.
Chan KSW; Lai NBW; Wong MMC; Pang PF
East Asian Arch Psychiatry; 2023 Mar; 33(1):28-31. PubMed ID: 36991553
[TBL] [Abstract][Full Text] [Related]
2. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
3. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
4. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
Joffe G; Eskelinen S; Sailas E
Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
[No Abstract] [Full Text] [Related]
5. A case of agranulocytosis secondary to rechallenge with clozapine following severe neutropenia during previous therapy.
Lertxundi U; Sanchez P; Hernandez R; Elizagarate E
J Clin Psychiatry; 2011 Dec; 72(12):1659. PubMed ID: 22244024
[No Abstract] [Full Text] [Related]
6. Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
Geibig CB; Marks LW
Ann Pharmacother; 1993 Oct; 27(10):1190-4. PubMed ID: 7504534
[TBL] [Abstract][Full Text] [Related]
7. Clozapine re-challenge under the cover of Filgrastim.
Gopalakrishnan R; Subhalakshmi TP; Kuruvilla A; Jacob KS
J Postgrad Med; 2013; 59(1):54-5. PubMed ID: 23525060
[TBL] [Abstract][Full Text] [Related]
8. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
[TBL] [Abstract][Full Text] [Related]
9. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
Gullion G; Yeh HS
J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
[TBL] [Abstract][Full Text] [Related]
10. Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.
Myles N; Myles H; Clark SR; Bird R; Siskind D
Aust N Z J Psychiatry; 2017 Oct; 51(10):980-989. PubMed ID: 28747065
[TBL] [Abstract][Full Text] [Related]
11. Clozapine rechallenge following neutropenia using granulocyte colony-stimulating factor: A Quebec case series.
Béchard L; Corbeil O; Plante M; Thivierge MA; Lafrenière CÉ; Roy MA; Demers MF
J Psychopharmacol; 2021 Sep; 35(9):1152-1157. PubMed ID: 34229529
[TBL] [Abstract][Full Text] [Related]
12. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
Majczenko TG; Stewart JT
South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis.
Nielsen H
J Intern Med; 1993 Nov; 234(5):529-31. PubMed ID: 7693847
[TBL] [Abstract][Full Text] [Related]
14. Treating chemotherapy induced agranulocytosis with granulocyte colony-stimulating factors in a patient on clozapine.
Kolli V; Denton K; Borra D; Pulluri M; Sharma A
Psychooncology; 2013 Jul; 22(7):1674-5. PubMed ID: 23059755
[TBL] [Abstract][Full Text] [Related]
15. Successful Use of Single Doses of Granulocyte-Colony Stimulating Factor (G-CSF) in the Treatment of Late-Onset Agranulocytosis Associated With Clozapine in a Patient With Treatment-Resistant Schizophrenia: A Case Report.
Comacchio C; Dusi N; Lasalvia A
J Clin Psychopharmacol; 2016 Apr; 36(2):173-4. PubMed ID: 26859277
[No Abstract] [Full Text] [Related]
16. Use of cytokines in clozapine-induced agranulocytosis.
Chin-Yee I; Bezchlibnyk-Butler K; Wong L
Can J Psychiatry; 1996 Jun; 41(5):280-4. PubMed ID: 8793147
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony stimulating factor (G-CSF) can allow treatment with clozapine in a patient with severe benign ethnic neutropaenia (BEN): a case report.
Spencer BW; Williams HR; Gee SH; Whiskey E; Rodrigues JP; Mijovic A; MacCabe JH
J Psychopharmacol; 2012 Sep; 26(9):1280-2. PubMed ID: 22719015
[TBL] [Abstract][Full Text] [Related]
18. [Clozapine rechallenge in resistant schizophrenia disorder affecting "super sensitive" patients, after neutropenia under clozapine: a case report].
Huguet G; Lillo-Le Louet A; Darnige L; Loo H; Krebs MO
Encephale; 2013 May; 39 Suppl 1():S42-8. PubMed ID: 23557674
[TBL] [Abstract][Full Text] [Related]
19. Clozapine-Associated Agranulocytosis Treatment With Granulocyte Colony-Stimulating Factor/Granulocyte-Macrophage Colony-Stimulating Factor: A Systematic Review.
Lally J; Malik S; Whiskey E; Taylor DM; Gaughran FP; Krivoy A; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Aug; 37(4):441-446. PubMed ID: 28437295
[TBL] [Abstract][Full Text] [Related]
20. The Use of Granulocyte Colony-Stimulating Factor in Clozapine Rechallenge: A Systematic Review.
Lally J; Malik S; Krivoy A; Whiskey E; Taylor DM; Gaughran FP; Flanagan RJ; Mijovic A; MacCabe JH
J Clin Psychopharmacol; 2017 Oct; 37(5):600-604. PubMed ID: 28817489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
